Mylan argued in its opposition brief that Hatch-Waxman Act patent suits cannot take place in venues where future generic drug sales may occur, and …
Mylan argued in its opposition brief that Hatch-Waxman Act patent suits cannot take place in venues where future generic drug sales may occur, and …